Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transaction
SEC Form 4 Filing
Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock on May 15, 2025.
Summary
- On May 15, 2025, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving the company's common stock.
- The transaction involved the vesting of restricted stock units, resulting in the disposition of 68 shares.
- Following the transaction, Potter directly owns 14,063 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it represents a routine vesting of previously granted equity.
Key Dates
| Date | Description |
|---|---|
| 10/15/2022 | Initial vesting date for 25% of the restricted stock unit award. |
| 05/15/2025 | Date of the reported transaction involving the vesting of restricted stock units. |
| 05/16/2025 | Date of signature for the Form 4 filing. |
Keywords
Guardant Health, Director, Stock Transaction, Form 4, Beneficial Ownership, Restricted Stock Units, Common Stock, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.